Romanian Society of Pharmaceutical Sciences
 

« Back to Farmacia Journal 6/2021

CLINICAL ASSESSMENT OF THE THERAPEUTIC OPTIONS FOR ALOPECIA TREATMENT

ANDREI MARIN 1#, SABINA-ELIZA BĂLOI 2*, DANIEL ION 3,7#, CĂTĂLINA-LILIANA
ANDREI 4,7#, SILVIU ADRIAN MARINESCU 5,7, GEORGE TRAIAN ALEXANDRU BURCEADRAGOMIROIU 6,7, CARMEN GIUGLEA 1,7

1Plastic Surgery Department, “Sf. Ioan” Hospital, 042122, Bucharest, Romania
2Aesthetic&Cosmetic Surgery Center, 011203, Bucharest, Romania
3Surgery III Department, Bucharest Emergency University Hospital, 050098, Bucharest, Romania
4Cardiology and Thoracic Pathology Department, “Bagdasar Arseni” Hospital, 041915, Bucharest, Romania
5Plastic Surgery Department, “Bagdasar Arseni” Hospital, 041915, Bucharest, Romania 6Drug Control Department, Faculty of Pharmacy, 031215, Bucharest, Romania 7“Carol Davila” University of Medicine and Pharmacy, 020021, Bucharest, Romania

Download Full Article PDF

Baldness has been a major aesthetic issue for men in general and solutions to solve this problem have been tried for several hundred years. Although there are cases in which alopecia is the result of a specific pathology (which can be treated accordingly), for many years baldness has been thought to be idiopathic or genetic and without treatment. Our study aims to evaluate different treatments: a topical mixture of finasteride and minoxidil, PRP (platelet rich plasma) infiltrations and oral medicine to stop hair loss and improve hair density and follicle diameter. The study was conducted on a series of patients exhibiting hair loss with or without a known medical cause.